SE442993B - Cyklohexyl-4-naftalen-ettiksyra-1-derivat, vilket kan anvendas som antiinflammatoriskt medel - Google Patents
Cyklohexyl-4-naftalen-ettiksyra-1-derivat, vilket kan anvendas som antiinflammatoriskt medelInfo
- Publication number
- SE442993B SE442993B SE7810294A SE7810294A SE442993B SE 442993 B SE442993 B SE 442993B SE 7810294 A SE7810294 A SE 7810294A SE 7810294 A SE7810294 A SE 7810294A SE 442993 B SE442993 B SE 442993B
- Authority
- SE
- Sweden
- Prior art keywords
- cyclohexyl
- compound
- naphthalene
- derivative
- inflammatory agent
- Prior art date
Links
- 229940121363 anti-inflammatory agent Drugs 0.000 title description 2
- 239000002260 anti-inflammatory agent Substances 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims description 26
- 239000002253 acid Substances 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 3
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical class C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 claims 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims 1
- 238000002360 preparation method Methods 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 229960002895 phenylbutazone Drugs 0.000 description 4
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
- 239000012346 acetyl chloride Substances 0.000 description 2
- -1 alkali metal cyanate Chemical class 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- MNWBNISUBARLIT-UHFFFAOYSA-N sodium cyanide Chemical compound [Na+].N#[C-] MNWBNISUBARLIT-UHFFFAOYSA-N 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- BPXITDRZRADOHD-UHFFFAOYSA-N 2-(4-cyclohexylnaphthalen-1-yl)acetic acid Chemical compound C12=CC=CC=C2C(CC(=O)O)=CC=C1C1CCCCC1 BPXITDRZRADOHD-UHFFFAOYSA-N 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- YUDRVAHLXDBKSR-UHFFFAOYSA-N [CH]1CCCCC1 Chemical compound [CH]1CCCCC1 YUDRVAHLXDBKSR-UHFFFAOYSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001351 alkyl iodides Chemical class 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000007265 chloromethylation reaction Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- XBEREOHJDYAKDA-UHFFFAOYSA-N lithium;propane Chemical compound [Li+].CC[CH2-] XBEREOHJDYAKDA-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000002790 naphthalenes Chemical class 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000009291 secondary effect Effects 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C17/00—Preparation of halogenated hydrocarbons
- C07C17/26—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton
- C07C17/32—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by introduction of halogenated alkyl groups into ring compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7729728A FR2404620A2 (fr) | 1977-10-03 | 1977-10-03 | Derives de l'acide cyclohexyl-4 naphtalene acetique-1, procede d'obtention et application a titre de medicament |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7810294L SE7810294L (sv) | 1979-04-04 |
| SE442993B true SE442993B (sv) | 1986-02-10 |
Family
ID=9196050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7810294A SE442993B (sv) | 1977-10-03 | 1978-10-02 | Cyklohexyl-4-naftalen-ettiksyra-1-derivat, vilket kan anvendas som antiinflammatoriskt medel |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4218473A (fr) |
| JP (1) | JPS5461161A (fr) |
| AT (1) | AT356089B (fr) |
| AU (1) | AU521195B2 (fr) |
| BE (1) | BE870553A (fr) |
| CA (1) | CA1100527A (fr) |
| CH (1) | CH635307A5 (fr) |
| DE (1) | DE2842495C2 (fr) |
| DK (1) | DK150846C (fr) |
| ES (1) | ES473909A1 (fr) |
| FI (1) | FI65424C (fr) |
| FR (1) | FR2404620A2 (fr) |
| GB (1) | GB2006763B (fr) |
| GR (1) | GR66032B (fr) |
| NL (2) | NL185143C (fr) |
| PT (1) | PT68611A (fr) |
| SE (1) | SE442993B (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103183604B (zh) * | 2011-12-28 | 2015-07-29 | 药源药物化学（上海）有限公司 | 维达洛芬的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3904682A (en) * | 1967-01-13 | 1975-09-09 | Syntex Corp | 2-(6{40 -Methoxy-2{40 -naphthyl)acetic acid |
| US3896157A (en) * | 1967-01-13 | 1975-07-22 | Syntex Corp | Dihydo 2-naphthylacetic acid derivatives |
| FR2115026B1 (fr) * | 1970-11-24 | 1974-03-22 | Logeais Labor Jacques |
-
1977
- 1977-10-03 FR FR7729728A patent/FR2404620A2/fr active Granted
-
1978
- 1978-09-18 BE BE190544A patent/BE870553A/fr not_active IP Right Cessation
- 1978-09-26 US US05/945,891 patent/US4218473A/en not_active Expired - Lifetime
- 1978-09-28 AU AU40266/78A patent/AU521195B2/en not_active Expired
- 1978-09-29 DK DK432478A patent/DK150846C/da not_active IP Right Cessation
- 1978-09-29 DE DE2842495A patent/DE2842495C2/de not_active Expired
- 1978-09-29 GR GR57337A patent/GR66032B/el unknown
- 1978-10-02 CH CH1021378A patent/CH635307A5/fr not_active IP Right Cessation
- 1978-10-02 JP JP12142378A patent/JPS5461161A/ja active Granted
- 1978-10-02 CA CA312,498A patent/CA1100527A/fr not_active Expired
- 1978-10-02 NL NLAANVRAGE7809949,A patent/NL185143C/xx not_active IP Right Cessation
- 1978-10-02 SE SE7810294A patent/SE442993B/sv not_active IP Right Cessation
- 1978-10-02 FI FI782993A patent/FI65424C/fi not_active IP Right Cessation
- 1978-10-02 PT PT68611A patent/PT68611A/fr unknown
- 1978-10-03 ES ES473909A patent/ES473909A1/es not_active Expired
- 1978-10-03 AT AT713578A patent/AT356089B/de not_active IP Right Cessation
- 1978-10-03 GB GB7839192A patent/GB2006763B/en not_active Expired
-
1996
- 1996-03-05 NL NL960003C patent/NL960003I2/nl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK432478A (da) | 1979-04-04 |
| DE2842495C2 (de) | 1983-05-19 |
| NL185143C (nl) | 1990-02-01 |
| JPS5461161A (en) | 1979-05-17 |
| GB2006763B (en) | 1982-03-17 |
| SE7810294L (sv) | 1979-04-04 |
| NL960003I2 (nl) | 1996-11-01 |
| US4218473A (en) | 1980-08-19 |
| GR66032B (fr) | 1981-01-14 |
| GB2006763A (en) | 1979-05-10 |
| DK150846B (da) | 1987-07-06 |
| FR2404620B2 (fr) | 1980-08-01 |
| FI65424C (fi) | 1984-05-10 |
| BE870553A (fr) | 1979-03-19 |
| AT356089B (de) | 1980-04-10 |
| AU521195B2 (en) | 1982-03-18 |
| CA1100527A (fr) | 1981-05-05 |
| CH635307A5 (fr) | 1983-03-31 |
| FI782993A7 (fi) | 1979-04-04 |
| ES473909A1 (es) | 1979-04-01 |
| DE2842495A1 (de) | 1979-04-19 |
| FI65424B (fi) | 1984-01-31 |
| DK150846C (da) | 1988-02-01 |
| JPS5640140B2 (fr) | 1981-09-18 |
| NL960003I1 (nl) | 1996-05-01 |
| ATA713578A (de) | 1979-09-15 |
| PT68611A (fr) | 1978-11-01 |
| FR2404620A2 (fr) | 1979-04-27 |
| NL7809949A (nl) | 1979-04-05 |
| NL185143B (nl) | 1989-09-01 |
| AU4026678A (en) | 1980-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0002892B1 (fr) | Dérivés d'amides, procédé pour leur préparation et compositions pharmaceutiques ou vétérinaires les contenant | |
| CA1077957A (fr) | Derives hypolipidemiques de type 4-monoalkylamino de l'acide benzoique | |
| US4058558A (en) | Aromatic keto acids and derivatives having analgetic, antiinflammatory, and hypocholesterolemizing action | |
| US4008323A (en) | Method of reducing cholesterol using certain aromatic keto acids | |
| PL115756B1 (en) | Process for preparing novel 1,1-dioxid-4-hydroxy-2h-1,2-benzothiazin-3-carboxyamides | |
| DE2814556A1 (de) | Substituierte phenylessigsaeurederivate und verfahren zu deren herstellung | |
| JPS6033114B2 (ja) | １，２−ベンズイソキサゾ−ル誘導体 | |
| EP0116360A1 (fr) | Composé de 1-phényl-2-aminocarbonylindole, leur préparation et les médicaments les contenant | |
| DE2546996A1 (de) | Neue phenoxyalkylcarbonsaeuren und verfahren zur herstellung derselben | |
| US4699925A (en) | Biphenylylpropionic acid derivative and pharmaceutical composition containing the same | |
| DE2816109A1 (de) | Neue pyrrolochinoxaline, verfahren zu deren herstellung und pharmazeutische zusammensetzungen | |
| SE442993B (sv) | Cyklohexyl-4-naftalen-ettiksyra-1-derivat, vilket kan anvendas som antiinflammatoriskt medel | |
| Johnson et al. | Gliotoxin. VII. Synthesis of Pyrazinoindolones and Pyridindolones1 | |
| EP0072960A2 (fr) | Composés 1,5-diphénylpyrazolin-3-one, ainsi qu'un procédé et produits intermédiaires pour leur fabrication et médicaments contenant ces composés | |
| US5519043A (en) | Fluorenyl derivatives | |
| JPS63119455A (ja) | グリシン誘導体 | |
| EP0000488A1 (fr) | Dérivés de 3-oxalylamino-4-oxo-4H-1-benzopyranes, procédé pour leur préparation et leur utilisation pharmaceutique | |
| CS216206B2 (en) | Method of making the derivatives of the diphenylpyrazole | |
| US3594388A (en) | 4-amino-5-(substituted phenyl) furazan | |
| CH629757A5 (en) | Process for the preparation of cyanoacetanilide derivatives | |
| US3170932A (en) | 2-aza-8-oxaspiro[4, 5]decane-1, 3-diones | |
| DE3300522A1 (de) | 3,3-dialkyl- und 3,3-alkylen-indolinderivate, verfahren zu ihrer herstellung und pharmazeutische praeparate sie enthaltend | |
| JPH0710863B2 (ja) | エーテル化若しくはエステル化しうるジヒドロキシ基により位置２で置換された４―ｏｈキノリンカルボン酸の新規の誘導体、その製造方法、及び医薬としてのその使用 | |
| CH461489A (de) | Verfahren zur Herstellung von neuen Oxazolderivaten | |
| US2140480A (en) | 3-keto-d-pentonic acid lactone and process for the manufacture of same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 7810294-4 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |
Ref document number: 7810294-4 Format of ref document f/p: F |